{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-005405","form_type":"8-K","ticker":"CLNN","cik":"0001822791","company_name":"Clene Inc.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.806249+00:00","generated_at":"2026-06-18T13:27:49.579019+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clene enters $25M equity purchase agreement with Lincoln Park Capital","bullets":["Lincoln Park commits to buy up to $25M of CLNN common stock over 36 months at company's discretion.","Company issued 332,668 initial commitment shares as fee; additional commitment shares possible.","Regular purchases limited to 75,000 shares per day (up to 200,000 if stock price above $4.00).","Purchase price at 97% of VWAP; proceeds for clinical development of CNM-Au8 and general corporate.","Issuance capped at 19.99% of outstanding without stockholder approval unless average price above $1.2404."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-005405","json":"https://secwatch.observer/filing/0001437749-23-005405.json","markdown":"https://secwatch.observer/filing/0001437749-23-005405.md","text":"https://secwatch.observer/filing/0001437749-23-005405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923005405/0001437749-23-005405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923005405/clnn20230222_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:27:49.579019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b3a643e9a03e734fbdf743afd95c2cc51f78b4ab","claim":"Clene Inc. entered into Purchase Agreement with Lincoln Park Capital Fund, LLC valued at up to $25,000,000 (effective 2023-03-03).","evidence_excerpt":"On March 3, 2023, Clene Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which Lincoln Park has committed to purchase up to $25,000,000 of shares (the “Purchase Shares”) of the Company's common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923005405/0001437749-23-005405-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Lincoln Park Capital Fund, LLC"},{"label":"Value","value":"up to $25,000,000"},{"label":"Effective","value":"2023-03-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}